$IKT
Inhibikase Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IKT up today? It is at $2.50 (+5.04%), and our scanner flagged it 10 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IKT spikes, and full due diligence on IKT — key stats, earnings, dilution and insider activity. Free.
Get free $IKT alerts the moment volume spikes
Our scanner flagged $IKT 10 times in the last 30 days. Create a free account to track $IKT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.50
- Change today
- +5.04%
- Previous close
- $2.38
- 52-week range
- $1.33 – $2.54
- Market cap
- $322M
- Institutional own.
- 87.71%
- Total held
- 94.8%
- Tradeable float
- 7.2M 5% of shares · after 7% insiders + 88% institutions
- Short interest
- 19.7M ▲ +3% vs prior · as of 2026-08-14
- Days to cover
- 35.5d
- Avg daily volume
- 889K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.5x
- 15m
- 0.6x
- 1h
- 0.7x
- 1D
- 0.3x
Get free IKT + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $IKT up today?
Here is the latest on IKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystChange of Accountant, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
4 open-market buys0 buys, 1 sells last 3 months (1/4 over 12 months)Show 10 recent transactionsMinimize 10 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Berman Dennis N Director | Other | 22K 0.02% of company | n/a | 22K | $28K at $1.26 | Jul 30, 26 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Sold (automatic/other) | -18.03M 12.9% of company | sold 72% | 6.97M | n/a | Jul 29, 26 |
Munshi Amit Director | Sold (automatic/other) | -19K 0.01% of company | sold 33% | 38K | n/a | Feb 21, 26 |
Cabell Christopher Officer | Sold (automatic/other) | -338K 0.2% of company | sold 33% | 677K | n/a | Feb 21, 26 |
Aurentz Vincent Director | Sold (automatic/other) | -255K 0.2% of company | sold 33% | 511K | n/a | Feb 21, 26 |
Sands Capital Life Sciences Pulse Fund Ii, L.P. Beneficial Owner (10%) | Bought (open market) | +2.07M 1.5% of company | added 19% | 13.02M | $3.0M at $1.45 | Nov 21, 25 |
Munshi Amit Director | Acquired (grant/award) | +57K 0.04% of company | n/a | 57K | n/a | Feb 21, 25 |
Munshi Amit Director | Bought (open market) | +365K 0.3% of company | n/a | 365K | $500K at $1.37 | Oct 21, 24 |
Kush Arvind Director | Bought (open market) | +145K 0.1% of company | n/a | 145K | $199K at $1.37 | Oct 21, 24 |
Bellini Roberto Director | Bought (open market) | +1.46M 1.0% of company | n/a | 1.46M | $2.0M at $1.37 | Oct 21, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $IKT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 116,352,201 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $185.0M in size · Priced at $1.59/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$IKT Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$IKT Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to IKT
Comparable names in biological products, (no diagnostic substances), closest in size first.
IKT stock FAQ
Why is $IKT up today?
Here is the latest on IKT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IKT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the IKT stock price today?
IKT last traded at $2.50, up 5.04% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live IKT alerts?
The IKT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IKT 10 times in the last 30 days.
What exchange is IKT on?
IKT (Inhibikase Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $322M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is IKT good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IKT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.